Announcements Trials
Browse Landscape

Status

Available 6No longer available 3Approved for marketing 2Temporarily not available 1

Sponsor Class

INDUSTRY 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Gastrointestinal 27Other hematologic neoplasm 25CNS 25Genitourinary 24Plasma cell 22Lymphoid 22Thoracic 20Dermatologic 20Sarcoma 18Breast 12Myeloid 10Other solid neoplasm 9Tumor-Agnostic 8Endocrine 8NET 4Other neoplasm 3Head & Neck 3Gynecologic 3Classical hematology 1

Conditions

Ovarian Neoplasms 2Uterine Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1PSR Ovarian Cancer With a BRCA Mutation 1Melanoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pegilodecakin 1olaparib 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
No longer available × Expanded_access × Gynecologic × Clear all
NCT04681248 2025-08-03

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Leap Therapeutics, Inc.

No longer available
GastrointestinalGynecologicSarcoma

Carcinoma, Squamous Cell, Carcinosarcoma, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT03554434 2020-03-02

An Expanded Access Program for AM0010 (Pegilodecakin)

Eli Lilly and Company

No longer available
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03063710 2018-05-17

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

AstraZeneca

No longer available
Gynecologic

PSR Ovarian Cancer With a BRCA Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡